| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.07B | 56.09B | 52.37B | 50.00B | 53.35B | 48.18B |
| Gross Profit | 20.72B | 22.03B | 21.29B | 20.11B | 22.96B | 20.56B |
| EBITDA | 14.89B | 14.16B | 14.23B | 12.09B | 14.99B | 13.20B |
| Net Income | 4.85B | 5.50B | 5.29B | 4.34B | 6.35B | 5.12B |
Balance Sheet | ||||||
| Total Assets | 64.27B | 65.33B | 68.59B | 61.12B | 64.49B | 59.23B |
| Cash, Cash Equivalents and Short-Term Investments | 3.17B | 4.68B | 5.29B | 3.68B | 6.88B | 4.41B |
| Total Debt | 3.70B | 2.43B | 3.46B | 4.02B | 6.17B | 8.38B |
| Total Liabilities | 15.71B | 16.53B | 23.72B | 19.81B | 25.86B | 24.75B |
| Stockholders Equity | 48.57B | 48.80B | 44.87B | 41.30B | 38.63B | 34.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.13B | 4.09B | 951.00M | 6.84B | 4.47B |
| Operating Cash Flow | 0.00 | 5.12B | 6.23B | 3.32B | 8.56B | 6.15B |
| Investing Cash Flow | 0.00 | -2.91B | -2.54B | -2.62B | -1.69B | -1.68B |
| Financing Cash Flow | 0.00 | -2.84B | -2.38B | -3.91B | -3.91B | -3.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥994.10B | 25.41 | 11.06% | 2.88% | 11.00% | 88.70% | |
75 Outperform | ¥244.81B | 8.22 | ― | 2.67% | 2.29% | -4.12% | |
72 Outperform | ¥1.17T | 9.44 | 19.60% | 1.94% | 3.13% | 11.87% | |
68 Neutral | ¥50.41B | 7.32 | ― | 4.01% | -5.36% | -8.38% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥148.77B | 10.72 | 14.78% | 2.95% | 17.74% | 19.41% | |
63 Neutral | ¥160.34B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% |